Adam Kole

Adam Kole is a Radiation Oncologist at the University of Alabama at Birmingham since August 2018, following a residency in Radiation Oncology at Yale School of Medicine from June 2014 to June 2018. Prior experience includes a Transitional Year Residency at Baptist Health System from June 2013 to June 2014 and an extensive educational background, having earned an MD and a PhD in Cell & Developmental Biology from the University of North Carolina at Chapel Hill. Adam also has research experience as a Research Assistant at the Friedrich Miescher Institute for Biomedical Research and GlaxoSmithKline, as well as a Research Intern at NIEHS. Adam completed a BA in Chemistry at Duke University.